1. Home
  2. TWIN vs ACIU Comparison

TWIN vs ACIU Comparison

Compare TWIN & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

HOLD

Current Price

$18.84

Market Cap

224.5M

Sector

Industrials

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$3.50

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWIN
ACIU
Founded
1918
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.5M
213.3M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
TWIN
ACIU
Price
$18.84
$3.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$12.00
$10.00
AVG Volume (30 Days)
34.0K
389.4K
Earning Date
02-04-2026
11-04-2025
Dividend Yield
0.83%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$347,837,000.00
$5,482,957.00
Revenue This Year
$10.79
N/A
Revenue Next Year
$8.43
$644.42
P/E Ratio
$782.37
N/A
Revenue Growth
14.24
N/A
52 Week Low
$6.16
$1.43
52 Week High
$19.33
$4.00

Technical Indicators

Market Signals
Indicator
TWIN
ACIU
Relative Strength Index (RSI) 68.79 55.11
Support Level $16.79 $3.32
Resistance Level $18.96 $3.80
Average True Range (ATR) 0.73 0.24
MACD 0.14 0.02
Stochastic Oscillator 93.29 56.34

Price Performance

Historical Comparison
TWIN
ACIU

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: